Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Advances in therapeutic interventions for patients with pulmonary arterial hypertension.

Literature DB >> 25602947

Advances in therapeutic interventions for patients with pulmonary arterial hypertension.

Marc Humbert¹, Edmund M T Lau², David Montani², Xavier Jaïs², Oliver Sitbon², Gérald Simonneau².

Abstract

Entities: Disease Species

Keywords: hypertension, pulmonary; prostaglandins; pulmonary arterial hypertension; pulmonary heart disease; receptors, endothelin; treatment; ventricular remodeling

Mesh：

Year: 2014 PMID： 25602947 DOI： 10.1161/CIRCULATIONAHA.114.006974

Source DB: PubMed Journal: Circulation ISSN： 0009-7322 Impact factor: 29.690

Keyword Cloud
Cited

× No keyword cloud information.

83 in total

1. Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model.

Authors: Marius M Hoeper; Tilmann Kramer; Zixuan Pan; Christina A Eichstaedt; Jens Spiesshoefer; Nicola Benjamin; Karen M Olsson; Katrin Meyer; Carmine Dario Vizza; Anton Vonk-Noordegraaf; Oliver Distler; Christian Opitz; J Simon R Gibbs; Marion Delcroix; H Ardeschir Ghofrani; Doerte Huscher; David Pittrow; Stephan Rosenkranz; Ekkehard Grünig
Journal: Eur Respir J Date: 2017-08-03 Impact factor: 16.671

Advances in therapeutic interventions for patients with pulmonary arterial hypertension.

1. Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model.

2. Ectopic upregulation of membrane-bound IL6R drives vascular remodeling in pulmonary arterial hypertension.

Review 3. Epidemiology and treatment of pulmonary arterial hypertension.

4. Inhaled sildenafil as an alternative to oral sildenafil in the treatment of pulmonary arterial hypertension (PAH).

5. Abnormal Glucose Metabolism and High-Energy Expenditure in Idiopathic Pulmonary Arterial Hypertension.

Review 6. Pulmonary hypertension in low- and middle-income countries with focus on sub-Saharan Africa.

Review 7. Models and Molecular Mechanisms of World Health Organization Group 2 to 4 Pulmonary Hypertension.

8. Key inflammatory pathways underlying vascular remodeling in pulmonary hypertension.

Review 9. Pharmacology of Pulmonary Arterial Hypertension: An Overview of Current and Emerging Therapies.

Review 10. The Action of Smooth Muscle Cell Potassium Channels in the Pathology of Pulmonary Arterial Hypertension.